Tumor-specific CD28 costimulatory bispecific antibodies enhance T cell activation in solid tumors

被引：1
|
作者：
Dragovich, Matthew A.
Davra, Viralkumar
Faber, Matthew S.
Kim, Yoon Kyung
Nisthal, Alex
Zeng, Veronica G.
Jacinto, Jonathan
Diaz, Juan E.
Truong, Thuy
Qi, Jing
Avery, Kendra N.
Rashid, Rumana
Lee, Sung-Hyung
Chu, Seung Y.
Bonzon, Christine
Love, Ruschelle
Bernett, Matthew J.
Ernst, James A.
Bahjat, Rena
Barlow, Norman J.
Desjarlais, John R.
Hedvat, Michael
Moore, Gregory L.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-2983
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2983
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Membrane Rafts in T Cell Activation: A Spotlight on CD28 Costimulation
    Zumerle, Sara
    Molon, Barbara
    Viola, Antonella
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [42] CD28 coreceptor signal transduction in T cell activation.
    June, CH
    Blair, PJ
    Riley, J
    Carroll, R
    StLouis, DC
    Levine, BL
    IMMUNOLOGY, 1996, 89 : SAA81 - SAA81
  • [43] A COSTIMULATORY ROLE FOR CD28 IN THE ACTIVATION OF CD4+ LYMPHOCYTES-T BY STAPHYLOCOCCAL ENTEROTOXIN-B
    GOLDBACHMANSKY, R
    KING, PD
    TAYLOR, AP
    DUPONT, B
    INTERNATIONAL IMMUNOLOGY, 1992, 4 (12) : 1351 - 1360
  • [44] Regulation of T cell activation by CD28 and CTLA4
    Noel, PJ
    Boise, LH
    Thompson, CB
    MECHANISMS OF LYMPHOCYTE ACTIVATION AND IMMUNE REGULATION VI: CELL CYCLE AND PROGRAMMED CELL DEATH IN THE IMMUNE SYSTEM, 1996, 406 : 209 - 217
  • [45] Tumor-specific T cell activation by recombinant immunoreceptors:: CD3ζ signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can ge integrated into one combined CD28/CD3ζ signaling receptor molecule
    Hombach, A
    Wieczarkowiecz, A
    Marquardt, T
    Heuser, C
    Usai, L
    Pohl, C
    Seliger, B
    Abken, H
    JOURNAL OF IMMUNOLOGY, 2001, 167 (11): : 6123 - 6131
  • [46] Tumor-specific allogeneic T cells treat solid tumors in mice
    不详
    Nature Reviews Clinical Oncology, 2009, 6 (3) : 126 - 126
  • [47] Tumors avoid elimination despite the activation of tumor-specific T cells
    Shilyansky, J
    FASEB JOURNAL, 2001, 15 (05): : A1230 - A1230
  • [48] T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors
    Marzo, AL
    Lake, RA
    Robinson, BWS
    Scott, B
    CANCER RESEARCH, 1999, 59 (05) : 1071 - 1079
  • [49] CD3xCD19 bispecific antibodies and CD28 bivalent antibodies enhance T-cell reactivity against autologous leukemic cells in pediatric B-all bone marrow
    Manzke, O
    Berthold, F
    Huebel, K
    Tesch, H
    Diehl, V
    Bohlen, H
    INTERNATIONAL JOURNAL OF CANCER, 1999, 80 (05) : 715 - 722
  • [50] The roles of CD28 and CD40 ligand in T cell activation and tolerance
    Howland, KC
    Ausubel, LJ
    London, CA
    Abbas, AK
    JOURNAL OF IMMUNOLOGY, 2000, 164 (09): : 4465 - 4470
12345